The efficacy of erythropoietin on acute spinal cord injury. An experimental study on a rat model

Archives of Orthopaedic and Trauma Surgery

Volumn 129, Issue 2, 2009, Pages 189-194

  Kontogeorgakos, Vasileios A ^a   Voulgaris, Spyridon ^a   Korompilias, Anastasios V ^a   Vekris, Marios ^a   Polyzoidis, Konstantinos S ^b   Bourantas, Konstantinos ^a   Beris, Alexandros E ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Acute spinal cord injury; EPO; Erythropoietin; Neuroprotection

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEURYSM CLIP; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; FUNCTIONAL STATUS; LAMINECTOMY; LOCOMOTION; MICTURITION DISORDER; NEUROPROTECTION; NONHUMAN; PARAPLEGIA; PRIORITY JOURNAL; RAT; RATING SCALE; SPINAL CORD INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; FEMALE; RATS; RATS, WISTAR; SPINAL CORD INJURIES; TREATMENT OUTCOME;

EID: 59749089064     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-008-0594-x     Document Type: Article

References (47)

1. Allen AR (1911) Surgery for experimental lesions of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA 57:878-880
2. Arishima Y, Takao S, Ichiro Y, Kazunori Y, Setsuro K (2006) Preventive effect of erythropoietin on spinal cord cell apoptosis following acute traumatic injury in rats. Spine 31:2432-2438
3. Baptiste D, Fehlings M (2006) Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 23:318-334
4. Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1-21
5. Bianchi R, Buyukakilli B, Brines M et al (2004) Erythropoietin both protect from and reverses experimental diabetic neuropathy. Proc Natl Acad Sci 101:823-828
6. Bracken MB, Shepard MJ, Collins WF et al (1990) A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N Engl J Med 322(20):1405-1411
7. Bracken MB, Shepard MJ, Holford TR et al (1997) Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. National Acute Spinal Cord Injury Study. JAMA 277:1597-1604
8. Brines M, Cerami A (2006) Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise. Kidney Int 70:246-250
9. Brines ML, Ghezzi P, Keenam S et al (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci 97:10526-10531
10. Calvillo L, Latini R, Kajstura J et al (2003) Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci 100:4802-4806
11. Celik M, Gökmen N, Erbayraktar S et al (2002) Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci 99:2258-2263
12. Cetin A, Nas K, Buyukbayram H, Ceviz A, Olmez G (2006) The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats. Eur Spine J 15:1539-1544
13. Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kB signalling cascades. Nature 412:641-647
14. Dusart I, Schwab ME (1994) Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 6:712-724
15. Eid T, Brines M (2002) Recombinant human erythropoietin for neuroprotection: What is the evidence? Clin Breast Cancer 3(Suppl 3):109-115
16. Gassmann M, Heinicke K, Soliz J et al (2003) Non-erythroid functions of erythropoietin. Adv Exp Med Biol 543:323-330
17. Geisler FH, Coleman WP, Grieco G et al (2001) The Sygen multi-center acute spinal cord injury study. Spine 26(Suppl 24):87-98
18. Gorio A, Gokmen N, Erbayraktar S et al (2002) Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc Natl Acad Sci 99:9450-9455
19. Gorio A, Madaschi L, Di Stefano B et al (2005) Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc Natl Acad Sci 102:16379-16384
20. Grasso G, Sfacteria A, Erbayraktar S et al (2006) Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative. J Neurosurg Spine 4:310-318
21. Grasso G, Sfacteria A, Passalacqua M et al (2005) Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin. Neurosurgery 56:821-827
22. Harada N, Taoka Y, Okajima K (2006) Role of prostacyclin in the development of compression trauma-induced spinal cord injury in rats. J Neurotrauma 23:1739-1749
23. Jacobson LO, Goldwasser E, Fried W, Plzak L (1957) Role of the kidney in erythropoiesis. Nature 179:633
24. Jelkmann W (1994) Biology of erythropoietin. Clin Invest 72(Suppl 6):3-10
25. Kaptanoglu E, Solaroglu I, Okutan O, Surucu HS, Akbiyik F, Beskonakli E (2004) Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: Effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 27:113-120
26. Kaufman JS, Reda DJ, Fye CL et al (1998) Subcutaneous compared with intravenous epoeitin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on erythropoietin in hemodialysis patients. N Engl J Med 339:578-583
27. Khan M, Griebel R, Rozdilsky B, Politis M (1985) Hemorrhagic changes in experimental spinal cord injury models. Can J Neurol Sci 12:259-262
28. Leist M, Ghezzi P, Grasso G (2004) Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-242
29. Lipton S (2004) Erythropoietin for neurologic protection and diabetic neuropathy. N Engl J Med 350(24):2516-2517
30. Lykissas MG, SAkellariou E, Vekris MD et al (2007) Axonal regeneration stimulated by erythropoietin: An experimental study in rats. J Neurosci Methods 164:107-115
31. Masuda S, Nagao M, Sasaki R (1999) Erythropoietic, neurotrophic, and angiogenic functions of erythropoietin and regulation of erythropoietin production. Int J Hematol 70:1-6
32. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R (1994) A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 269:19488-19493
33. Minoda Y, Sakawa A, Fukuoka S, Tada K, Takaoka K (2004) Blood management for patients with hemoglobin level lower than 130 g/l in total knee arthroplasty. Arch Orthop Trauma Surg 124(5):317-319
34. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R (1997) Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76:105-116
35. Rivlin AS, Tator CH (1978) Effect of duration of acute spinal cord compression in a new acute cord injury in the rat. Surg Neurol 10:38-43
36. Sasaki R, Masuda S, Nagao M (2000) Erythropoietin: Multiple physiological functions and regulation of biosynthesis. Biosci Biotechnol Biochem 64:1775-1793
37. Sayer FT, Kronvall E, Nilsson OG (2006) Methylprednisolone treatment in acute spinal cord injury: The myth challenged through a structured analysis of published literature. Spine J 6:335-343
38. Schwartz G, Fehlings MG (2001) Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: Improved behavioral and neuroanatomical recovery with riluzole. J Neurosurg Spine 94:245-256
39. Sekhon LH, Fehlings MG (2001) Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26(Suppl 24):2-12
40. Sekiguchi Y, Kikuchi S, Myers RR., Campana WM (2003) Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush. Spine 28:2577-2584
41. Shi R, Borgens RB (2000) Anatomical repair of nerve membranes in crushed mammalian spinal cord with polyethylene glycol. J Neurocytol 29:633-643
42. Shingo T, Sorokan ST, Shimazaki T, Weiss S (2001) Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 21:9733-9743
43. Siren AL, Knerlich F, Poser W, Gleiter CH, Bruck W, Ehrenreich H (2001) Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol (Berl) 101:271-276
44. Stohlawetz PJ, Dzirlo L, Hergovich N (2000) Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood 95:2983-2989
45. Tator CH (1995) Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 5:407-413
46. Wells JE, Hurlbert RJ, Fehlings MG et al (2003) Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 126:1628-1637
47. Wolf RF, Peng J, Friese P, Gilmore LS, Burstein SA, Dale GL (1997) Erythropoietin administration increases production and reactivity of platelets in dogs. Thromb Haemost 78:1505-1509